In both T2D and CHC patients, IL-1α, IL-2R, IL-12, IL-18, MIF, insulin, leptin, PAI-1, resistin and adipsin are increased whereas ghrelin is decreased with respect to healthy controls (Table 2 and Figures 1–2). This evidence concerns the gene RETN and type 2 diabetes mellitus.